Disclosure (CRR)

1.

Institutions shall disclose their risk management objectives and policies for each separate category of risk, including the risks referred to in this Title. These disclosures shall include:

1. (a) the strategies and processes to manage those categories of risks;
2. (b) the structure and organisation of the relevant risk management function including information on the basis of its authority, its powers and accountability in accordance with the institution's incorporation and governing documents;
3. (c) the scope and nature of risk reporting and measurement systems;
4. (d) the policies for hedging and mitigating risk, and the strategies and processes for monitoring the continuing effectiveness of hedges and mitigants;
5. (e) a declaration approved by the management body on the adequacy of risk management arrangements of the institution providing assurance that the risk management systems put in place are adequate with regard to the institution's profile and strategy;
6. (f) a concise risk statement approved by the management body succinctly describing the relevant institution's overall risk profile associated with the business strategy; that statement shall include:
1. (i) key ratios and figures providing external stakeholders with a comprehensive view of the institution's management of risk, including how the risk profile of the institution interacts with the risk tolerance set by the management body;
2. (ii) information on intragroup transactions and transactions with related parties that may have a material impact of the risk profile of the consolidated group.

2.

Institutions shall disclose the following information regarding governance arrangements:

1. (a) the number of directorships held by members of the management body;
2. (b) the recruitment policy for the selection of members of the management body and their actual knowledge, skills and expertise;
3. (c) the policy on diversity with regard to selection of members of the management body, its objectives and any relevant targets set out in that policy, and the extent to which those objectives and targets have been achieved;
4. (d) whether or not the institution has set up a separate risk committee and the number of times the risk committee has met;
5. (e) the description of the information flow on risk to the management body.

[Note: This rule corresponds to Article 435 of the CRR as it applied immediately before revocation by the Treasury]

Institutions shall disclose the following information regarding the scope of application of the CRR as follows:

1. (a) the name of the institution to which the CRR applies;
2. (b) a reconciliation between the consolidated financial statements prepared in accordance with the applicable accounting framework and the consolidated financial statements prepared in accordance with the requirements on regulatory consolidation pursuant to Sections 2 and 3 of Title II of Part One; that reconciliation shall outline the differences between the accounting and regulatory scopes of consolidation and the legal entities included within the regulatory scope of consolidation where it differs from the accounting scope of consolidation; the outline of the legal entities included within the regulatory scope of consolidation shall describe the method of regulatory consolidation where it is different from the accounting consolidation method, whether those entities are fully or proportionally consolidated and whether the holdings in those legal entities are deducted from own funds;
3. (c) a breakdown of assets and liabilities of the consolidated financial statements prepared in accordance with the requirements on regulatory consolidation pursuant to Sections 2 and 3 of Title II of Part One, broken down by type of risks as referred to under this Part;
4. (d) a reconciliation identifying the main sources of differences between the carrying value amounts in the financial statements under the regulatory scope of consolidation as defined in Sections 2 and 3 of Title II of Part One, and the exposure amount used for regulatory purposes; that reconciliation shall be supplemented by qualitative information on those main sources of differences;
5. (e) for exposures from the trading book and the non-trading book that are adjusted in accordance with Article 34 and Article 105, a breakdown of the amounts of the constituent elements of an institution's prudent valuation adjustment, by type of risks, and the total of constituent elements separately for the trading book and non-trading book positions;
6. (f) any current or expected material practical or legal impediment to the prompt transfer of own funds or repayment of liabilities between the parent undertaking and its subsidiaries;
7. (g) the aggregate amount by which the actual own funds are less than required in all subsidiaries that are not included in the consolidation, and the name or names of those subsidiaries;
8. (h) where applicable, the circumstances under which use is made of the derogation referred to in Article 7 or the individual consolidation method laid down in Article 9.

[Note: This rule corresponds to Article 436 of the CRR as it applied immediately before revocation by the Treasury]

Institutions shall disclose the following information regarding their own funds:

1. (a) a full reconciliation of Common Equity Tier 1 items, Additional Tier 1 items, Tier 2 items and filters and deductions applied to own funds of the institution pursuant to Articles 32 to 36, 56, 66 and 79 with the balance sheet in the audited financial statements of the institution;
2. (b) a description of the main features of the Common Equity Tier 1 and Additional Tier 1 instruments and Tier 2 instruments issued by the institution;
3. (c) the full terms and conditions of all Common Equity Tier 1, Additional Tier 1 and Tier 2 instruments;
4. (d) a separate disclosure of the nature and amounts of the following:
1. (i) each prudential filter applied pursuant to Articles 32 to 35;
2. (ii) items deducted pursuant to Articles 36, 56 and 66;
3. (iii) items not deducted pursuant to Articles 47, 48, 56, 66 and 79;
5. (e) a description of all restrictions applied to the calculation of own funds in accordance with the CRR and the instruments, prudential filters and deductions to which those restrictions apply;
6. (f) a comprehensive explanation of the basis on which capital ratios are calculated where those capital ratios are calculated by using elements of own funds determined on a basis other than the basis laid down in the CRR.

[Note: This rule corresponds to Article 437 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions that are subject to Article 92a, or are material subsidiaries of non-UK G-SIIs and are not resolution entities or subsidiaries of a UK parent institution, shall disclose the following information regarding their own funds and eligible liabilities:

1. (a) the composition of their own funds and eligible liabilities, their maturity and their main features;
2. (b) the ranking of eligible liabilities in the creditor hierarchy;
3. (c) the total amount of each issuance of eligible liabilities instruments referred to in Article 72b and the amount of those issuances that is included in eligible liabilities items within the limits specified in Article 72b(3) and (4);
4. (d) the total amount of excluded liabilities referred to in Article 72a(2).

[Note: This rule corresponds to Article 437a of the CRR as it applied immediately before revocation by the Treasury.]

Institutions shall disclose the following information regarding their compliance with Article 92 and rules 3.1(1)(a) and 3.4 of the Internal Capital Adequacy Assessment Part of the PRA Rulebook:

1. (a) a summary of their approach to assessing the adequacy of their internal capital to support current and future activities;
2. (b) the amount of the additional own funds requirements based on the supervisory review and evaluation process (within the meaning of regulation 34A of the Capital Requirements Regulations) and its composition in terms of Common Equity Tier 1, additional Tier 1 and Tier 2 instruments;
3. (c) the result of the institution's internal capital adequacy assessment process;
4. (d) the total risk-weighted exposure amount and the corresponding total own funds requirement determined in accordance with Article 92, to be broken down by the different risk categories set out in Part Three and, where applicable, an explanation of the effect on the calculation of own funds and risk-weighted exposure amounts that results from applying capital floors and not deducting items from own funds;
5. (e) the on- and off-balance-sheet exposures, the risk-weighted exposure amounts and associated expected losses for each category of specialised lending referred to in Table 1 of Article 153(5) and the on- and off-balance-sheet exposures and risk-weighted exposure amounts for the categories of equity exposures set out in Article 155(2);
6. (f) the exposure value and the risk-weighted exposure amount of own funds instruments held in any insurance undertaking, reinsurance undertaking or insurance holding company that the institutions do not deduct from their own funds in accordance with Article 49 when calculating their capital requirements on an individual, sub-consolidated and consolidated basis;
7. (g) the supplementary own funds requirement and the capital adequacy ratio of the financial conglomerate calculated in accordance with the provisions implementing Article 6 of Directive 2002/87/EC and Annex I to that Directive where method 1 or 2 set out in that Annex is applied;
8. (h) the variations in the risk-weighted exposure amounts of the current disclosure period compared to the immediately preceding disclosure period that result from the use of internal models, including an outline of the key drivers explaining those variations.

[Note: This rule corresponds to Article 438 of the CRR as it applied immediately before revocation by the Treasury]

Institutions shall disclose the following information regarding their exposure to counterparty credit risk as referred to in Chapter 6 of Title II of Part Three:

1. (a) a description of the methodology used to assign internal capital and credit limits for counterparty credit exposures, including the methods to assign those limits to exposures to central counterparties;
2. (b) a description of policies related to guarantees and other credit risk mitigants, such as the policies for securing collateral and establishing credit reserves;
3. (c) a description of policies with respect to General Wrong-Way risk and Specific Wrong-Way risk as defined in Article 291;
4. (d) the amount of collateral the institution would have to provide if its credit rating were downgraded;
5. (e) for derivative transactions, the amount of segregated and unsegregated collateral received and posted per type of collateral; and for securities financing transactions, the total amount of collateral received and posted per type of collateral; provided in each case that:
1. (i) institutions shall not disclose such amounts unless both the fair value of collateral posted in the form of debt securities and the fair value of collateral received in that form exceed GBP 125 billion; and
2. (ii) for the purposes of subparagraph (i), institutions shall use the twelve month rolling arithmetic mean of the fair value of collateral received or posted (as the case may be) in the form of debt securities, determined using quarterly data calculated in a manner consistent with data reported under Article 430(g) and covering the twelve months immediately preceding the disclosure reference date;
6. (f) for derivative transactions, the exposure values before and after the effect of the credit risk mitigation as determined under the methods set out in Sections 3 to 6 of Chapter 6 of Title II of Part Three, whichever method is applicable, and the associated risk exposure amounts broken down by applicable method;
7. (g) for securities financing transactions, the exposure values before and after the effect of the credit risk mitigation as determined under the methods set out in Chapters 4 and 6 of Title II of Part Three, whichever method is used, and the associated risk exposure amounts broken down by applicable method;
8. (h) the exposure values after credit risk mitigation effects and the associated risk exposures for credit valuation adjustment capital charge, separately for each method as set out in Title VI of Part Three;
9. (i) the exposure value to central counterparties and the associated risk exposures within the scope of Section 9 of Chapter 6 of Title II of Part Three, separately for qualifying and non-qualifying central counterparties, and broken down by types of exposures;
10. (j) the notional amounts and fair value of credit derivative transactions; credit derivative transactions shall be broken down by product type; within each product type, credit derivative transactions shall be broken down further by credit protection bought and credit protection sold;
11. (k) the estimate of alpha where the institution has received the permission of the competent authorities to use its own estimate of alpha in accordance with Article 284(9);
12. (m) for institutions using the methods set out in Sections 4 to 5 of Chapter 6 of Title II Part Three, the size of their on- and off-balance-sheet derivative business as calculated in accordance with Article 273a(1) or (2), as applicable.

[Note: This rule corresponds to Article 439 of the CRR as it applied immediately before revocation by the Treasury]

Institutions shall disclose the following information in relation to their compliance with the requirement for a countercyclical capital buffer referred to in regulation 2 of the Capital Requirements (Capital Buffers and Macro-prudential Measures) Regulations 2014:

1. (a) the geographical distribution of the exposure amounts and risk-weighted exposure amounts of its credit exposures used as a basis for the calculation of their countercyclical capital buffer;
2. (b) the amount of their institution-specific countercyclical capital buffer.

[Note: This rule corresponds to Article 440 of the CRR as it applied immediately before revocation by the Treasury.]

G-SIIs shall disclose, on an annual basis, the values of the indicators used for determining their score in accordance with the identification methodology referred to in regulation 23 of Part 4 of Capital Requirements (Capital Buffers and Macro-prudential Measures) Regulations 2014.

[Note: This rule corresponds to Article 441 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions shall disclose the following information regarding their exposure to credit risk and dilution risk:

1. (a) the scope and definitions that they use for accounting purposes of ‘past due’ and ‘impaired’ and the differences, if any, between the definitions of ‘past due’ and ‘default’ for accounting and regulatory purposes;
2. (b) a description of the approaches and methods adopted for determining specific and general credit risk adjustments;
3. (c) information on the amount and quality of performing, non-performing and forborne exposures for loans, debt securities and off-balance-sheet exposures, including their related accumulated impairment, provisions and negative fair value changes due to credit risk and amounts of collateral and financial guarantees received;
4. (d) an ageing analysis of accounting past due exposures;
5. (e) the gross carrying amounts of both defaulted and non-defaulted exposures, the accumulated specific and general credit risk adjustments, the accumulated write-offs taken against those exposures and the net carrying amounts and their distribution by geographical area and industry type and for loans, debt securities and off-balance-sheet exposures;
6. (f) any changes in the gross amount of defaulted on- and off-balance-sheet exposures, including, as a minimum, information on the opening and closing balances of those exposures, the gross amount of any of those exposures reverted to non-defaulted status or subject to a write-off;
7. (g) the breakdown of loans and debt securities by residual maturity.

[Note: This rule corresponds to Article 442 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions shall disclose information concerning their encumbered and unencumbered assets. For those purposes, institutions shall use the carrying amount per exposure class broken down by asset quality and the total amount of the carrying amount that is encumbered and unencumbered. Disclosure of information on encumbered and unencumbered assets shall not reveal emergency liquidity assistance provided by central banks.

[Note: This rule corresponds to Article 443 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions calculating their risk-weighted exposure amounts in accordance with Chapter 2 of Title II of Part Three shall disclose the following information for each of the exposure classes set out in Article 112:

1. (a) the names of the nominated ECAIs and export credit agencies and the reasons for any changes in those nominations over the disclosure period;
2. (b) the exposure classes for which each ECAI or export credit agency is used;
3. (c) a description of the process used to transfer the issuer and issue credit ratings onto items not included in the trading book;
4. (d) the association of the external rating of each nominated ECAI or export credit agency with the risk weights that correspond to the credit quality steps as set out in Chapter 2 of Title II of Part Three taking into account that it is not necessary to disclose that information where the institutions comply with the standard association published by the competent authority;
5. (e) the exposure values and the exposure values after credit risk mitigation associated with each credit quality step as set out in Chapter 2 of Title II of Part Three, by exposure class, as well as those deducted from own funds.

[Note: This rule corresponds to Article 444 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions calculating their own funds requirements in accordance with points (b) and (c) of Article 92(3) shall disclose those requirements separately for each risk referred to in those provisions. In addition, own funds requirements for the specific interest rate risk of securitisation positions shall be disclosed separately.

[Note: This rule corresponds to Article 445 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions shall disclose the following information about their operational risk management:

1. (a) the approaches for the assessment of own funds requirements for operational risk that the institution qualifies for;
2. (b) where the institution makes use of it, a description of the methodology set out in Article 312(2), which shall include a discussion of relevant internal and external factors being considered in the institution's advanced measurement approach;
3. (c) in the case of partial use, the scope and coverage of the different methodologies used.

[Note: This rule corresponds to Article 446 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions shall disclose the following key metrics in a tabular format:

1. (a) the composition of their own funds and their own funds requirements as calculated in accordance with Article 92;
2. (b) the total risk exposure amount as calculated in accordance with Article 92(3);
3. (c) where applicable, the amount and composition of additional own funds which the institutions are required to hold in accordance with regulation 34(1) of the Capital Requirements Regulations;
4. (d) their combined buffer requirement which the institutions are required to hold in accordance with regulation 35 of the Capital Requirements (Capital Buffers and Macro-prudential Measures) Regulations 2014;
5. (e) the following information in relation to their leverage ratio:
   1. (i) for all institutions, their leverage ratio and total exposure measure;
   2. (ii) for LREQ firms, the information in Article 451(1)(b) and (g) and Article 451(2)(b) to (d);
6. (f) the following information in relation to their liquidity coverage ratio as calculated in accordance with Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook:
7. (g) the following information in relation to their net stable funding requirement as calculated in accordance with Title IV of Part Six:
8. (h) their own funds and eligible liabilities ratios and their components, numerator and denominator, as calculated in accordance with Article 92a or, in the case of institutions that are material subsidiaries of non-UK G-SIIs and are not resolution entities or subsidiaries of a UK parent institution, in accordance with a direction from the Bank of England under section 3A(4B) of the Banking Act 2009, and broken down at the level of each resolution group, where applicable.

[Note: With effect from 1 July 2024, paragraph (g) is disapplied for SDDTs and SDDT consolidation entities by Chapter 5 of the Liquidity (CRR) Part where certain conditions are met]

[Note: Paragraph (h) of this rule corresponds to Article 447(h) of the CRR as it applied immediately before revocation by the Treasury.]

1.

Institutions shall disclose the following quantitative and qualitative information on the risks arising from potential changes in interest rates that affect both the economic value of equity and the net interest income of their non-trading book activities referred to in in Chapter 9 of the Internal Capital Adequacy Assessment (ICAA) Part of the PRA Rulebook:

1. (a) the changes in the economic value of equity calculated under the following six supervisory shock scenarios referred to in Rule 9.7 of the ICAA Part of the PRA Rulebook for the current and previous disclosure periods:
1. (i) parallel shock up;
2. (ii) parallel shock down;
3. (iii) steepener shock (short rates down and long rates up);
4. (iv) flattener shock (short rates up and long rates down);
5. (v) short rates shock up;
6. (vi) short rates shock down;
2. (b) the changes in the net interest income calculated under the following two supervisory shock scenarios referred to in Rule 9.7 of the ICAA Part of the PRA Rulebook for the current and previous disclosure periods:
3. (i) parallel shock up;
4. (ii) parallel shock down;
5. (c) a description of key modelling and parametric assumptions used to calculate changes in the economic value of equity and in the net interest income required under points (a) and (b) of this paragraph;
6. (d) an explanation of the significance of the risk measures disclosed under points (a) and (b) of this paragraph and of any significant variations of those risk measures since the previous disclosure reference date;
7. (e) the description of how institutions define, measure, mitigate and control the interest rate risk of their non-trading book activities for the purposes of the competent authorities' review in accordance with Chapter 9 of the ICAA Part of the PRA Rulebook, including:
1. (i) a description of the specific risk measures that the institutions use to evaluate changes in their economic value of equity and in their net interest income;
2. (ii) a description of the key modelling and parametric assumptions used in the institutions' internal measurement systems for the purpose of calculating changes in the economic value of equity and in net interest income, as required under points (a) and (b) of this paragraph, if those assumptions differ from those used for the purposes of Chapter 9 of the ICAA Part of the PRA Rulebook or from those specified in Annex XXXVIII of Chapter 6 of this Disclosure (CRR) Part of the PRA Rulebook, including the rationale for those differences;
3. (iii) a description of the interest rate shock scenarios that institutions use to estimate the interest rate risk;
4. (iv) the recognition of the effect of hedges against those interest rate risks, including internal hedges that meet the requirements laid down in Article 106(3);
5. (v) an outline of how often the evaluation of the interest rate risk occurs;
8. (f) the description of the overall risk management and mitigation strategies for those risks;
9. (g) average and longest repricing maturity assigned to non-maturing deposits.

2.

By way of derogation from paragraph 1 of this Article, the requirements set out in points (c) and (e)(i) to (e)(iv) of paragraph 1 of this Article for descriptions relating to economic value of equity shall not apply to institutions that use the standardised framework referred to in Rule 9.1B of the ICAA Part of the PRA Rulebook.

[Note: This rule corresponds to Article 448 of the CRR as it applied immediately before revocation by the Treasury.]

Institutions calculating risk-weighted exposure amounts in accordance with Chapter 5 of Title II of Part Three or own funds requirements in accordance with Article 337 or 338 shall disclose the following information separately for their trading and non-trading book activities:

1. (a) a description of their securitisation and re-securitisation activities, including their risk management and investment objectives in connection with those activities, their role in securitisation and re-securitisation transactions, whether they use the simple, transparent and standardised securitisation (STS) as defined in point (10) of Article 242, and the extent to which they use securitisation transactions to transfer the credit risk of the securitised exposures to third parties with, where applicable, a separate description of their synthetic securitisation risk transfer policy;
2. (b) the type of risks they are exposed to in their securitisation and re-securitisation activities by level of seniority of the relevant securitisation positions providing a distinction between STS and non-STS positions and:
1. (i) the risk retained in own-originated transactions;
2. (ii) the risk incurred in relation to transactions originated by third parties;
3. (c) their approaches for calculating the risk-weighted exposure amounts that they apply to their securitisation activities, including the types of securitisation positions to which each approach applies and with a distinction between STS and non-STS positions;
4. (d) a list of SSPEs falling into any of the following categories, with a description of their types of exposures to those SSPEs, including derivative contracts:
1. (i) SSPEs which acquire exposures originated by the institutions;
2. (ii) SSPEs sponsored by the institutions;
3. (iii) SSPEs and other legal entities for which the institutions provide securitisation-related services, such as advisory, asset servicing or management services;
4. (iv) SSPEs included in the institutions' regulatory scope of consolidation;
5. (e) a list of any legal entities in relation to which the institutions have disclosed that they have provided support in accordance with Chapter 5 of Title II of Part Three;
6. (f) a list of legal entities affiliated with the institutions and that invest in securitisations originated by the institutions or in securitisation positions issued by SSPEs sponsored by the institutions;
7. (g) a summary of their accounting policies for securitisation activity, including where relevant a distinction between securitisation and re-securitisation positions;
8. (h) the names of the ECAIs used for securitisations and the types of exposure for which each agency is used;
9. (i) where applicable, a description of the Internal Assessment Approach as set out in Chapter 5 of Title II of Part Three, including the structure of the internal assessment process and relation between internal assessment and external ratings of the relevant ECAI disclosed in accordance with point (h), the control mechanisms for the internal assessment process including discussion of independence, accountability, and internal assessment process review, the exposure types to which the internal assessment process is applied and the stress factors used for determining credit enhancement levels;
10. (j) separately for the trading book and the non-trading book, the carrying amount of securitisation exposures, including information on whether institutions have transferred significant credit risk in accordance with Articles 244 and 245, for which institutions act as originator, sponsor or investor, separately for traditional and synthetic securitisations, and for STS and non-STS transactions and broken down by type of securitisation exposures;
11. (k) for the trading and the non-trading book activities, the following information:
1. (i) the aggregate amount of securitisation positions where institutions act as originator or sponsor and the associated risk-weighted assets and capital requirements by regulatory approaches, including exposures deducted from own funds or risk weighted at 1250%, broken down between traditional and synthetic securitisations and between securitisation and re-securitisation exposures, separately for STS and non-STS positions, and further broken down into a meaningful number of risk-weight or capital requirement bands and by approach used to calculate the capital requirements ;
2. (ii) the aggregate amount of securitisation positions where institutions act as investor and the associated risk-weighted assets and capital requirements by regulatory approaches, including exposures deducted from own funds or risk weighted at 1250%, broken down between traditional and synthetic securitisations, securitisation and re-securitisation positions, and STS and non-STS positions, and further broken down into a meaningful number of risk weight or capital requirement bands and by approach used to calculate the capital requirements;
12. (l) for exposures securitised by the institution, the amount of exposures in default and the amount of the specific credit risk adjustments made by the institution during the current period, both broken down by exposure type.

[Note: This rule corresponds to Article 449 of the CRR as it applied immediately before revocation by the Treasury.]

1.

Institutions shall disclose the following information regarding their remuneration policy and practices for those categories of staff whose professional activities have a material impact on risk profile of the institutions:

1. (a) information concerning the decision-making process used for determining the remuneration policy, as well as the number of meetings held by the main body overseeing remuneration during the financial year, including, where applicable, information about the composition and the mandate of a remuneration committee, the external consultant whose services have been used for the determination of the remuneration policy and the role of the relevant stakeholders;
2. (b) information about the link between pay of the staff and their performance;
3. (c) the most important design characteristics of the remuneration system, including information on the criteria used for performance measurement and risk adjustment, deferral policy and vesting criteria;
4. (d) the ratios between fixed and variable remuneration set in accordance with rule 15.9 of the Remuneration Part;
5. (e) information on the performance criteria on which the entitlement to shares, options or variable components of remuneration is based;
6. (f) the main parameters and rationale for any variable component scheme and any other non-cash benefits;
7. (g) aggregate quantitative information on remuneration, broken down by business area;
8. (h) aggregate quantitative information on remuneration, broken down by senior management and members of staff whose professional activities have a material impact on the risk profile of the institutions, indicating the following:
1. (i) the amounts of remuneration for the financial year, split into fixed remuneration including a description of the fixed components, and variable remuneration, and the number of beneficiaries;
2. (ii) the amounts and forms of awarded variable remuneration, split into cash, shares, share-linked instruments and other types separately for the part paid upfront and the deferred part;
3. (iii) the amounts of deferred remuneration awarded for previous performance periods, split into the amount due to vest in the financial year and the amount due to vest in subsequent years;
4. (iv) the amount of deferred remuneration due to vest in the financial year, and the number of beneficiaries of those awards;
5. (v) the guaranteed variable remuneration awards during the financial year, and the number of beneficiaries of those awards;
6. (vi) severance payments awarded in previous periods, that have been paid out during the financial year;
7. (vii) the amounts of severance payments awarded during the financial year, split into paid upfront and deferred, the number of beneficiaries of those payments and highest payment that has been awarded to a single person;
9. (i) the number of individuals that have been remunerated EUR 1 million or more per financial year, with the remuneration between EUR 1 million and EUR 5 million broken down into pay bands of EUR 500 000 and with the remuneration of EUR 5 million and above broken down into pay bands of EUR 1 million;
10. (j) [Note: Provision deleted]
11. (k) information on whether the institution benefits from a derogation laid down in the Remuneration Part of the PRA Rulebook at 5.3, and/or 12.2 (second subparagraph), and 15.A1(3).

For the purposes of point (k) of the first subparagraph of this paragraph, institutions that benefit from such a derogation shall indicate whether they benefit from that derogation on the basis of the Remuneration Part of the PRA Rulebook at 5.3, and/or 12.2 (second subparagraph), and 15.A1(3). They shall also indicate for which of the remuneration principles they apply the derogation(s), the number of staff members that benefit from the derogation(s) and their total remuneration, split into fixed and variable remuneration.

2.

For large institutions, the quantitative information on the remuneration of institutions' collective management body referred to in this Article shall also be made available to the public, differentiating between executive and non-executive members.

Institutions shall comply with the requirements set out in this Article in a manner that is appropriate to their size, internal organisation and the nature, scope and complexity of their activities and without prejudice to the GDPR.

[Note: This rule corresponds to Article 450 of the CRR as it applied immediately before revocation by the Treasury.]

1.

Institutions shall disclose the following information regarding their leverage ratio as calculated in accordance with Article 429 of Chapter 3 of the Leverage Ratio (CRR) Part and their management of the risk of excessive leverage:

1. (a) the leverage ratio;
2. (b) the leverage ratio calculated as if central bank claims were required to be included in the total exposure measure;
3. (c) a breakdown of the total exposure measure, as well as a reconciliation of the total exposure measure with the relevant information disclosed in published financial statements;
4. (d) a description of the processes used to manage the risk of excessive leverage;
5. (e) a description of the factors that had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers;
6. (f) in relation to the quarterly periods up to 31 December 2022, the leverage ratio calculated as if Article 468 of the CRR did not apply for purposes of the capital measure under Article 429(3) of Chapter 3 of the Leverage Ratio (CRR) Part;
7. (g) in relation to the quarterly periods up to 31 December 2024, the leverage ratio calculated as if Article 473a of the CRR did not apply for purposes of the capital measure under Article 429(3) of Chapter 3 of the Leverage Ratio (CRR) Part.

2.

An LREQ firm must disclose each of the following:

1. (a) the average exposure measure;
2. (b) the average leverage ratio;
3. (c) the average leverage ratio calculated as if central bank claims were required to be included in the total exposure measure;
4. (d) the countercyclical leverage ratio buffer; and
5. (e) any additional leverage ratio buffer.

3.

An LREQ firm must disclose such information as is necessary to enable users to understand changes in the firm’s total exposure measure and tier 1 capital (leverage) over the quarter that have affected the firm’s average leverage ratio.

4.

1. (a) For the purposes of paragraph 2(a) an LREQ firm must calculate its average exposure measure for a quarter as the sum of:
1. (i) the arithmetic mean of the firm’s total exposure measure in relation to on-balance sheet assets and securities financing transactions on each day in the quarter; and
2. (ii) the arithmetic mean of the firm’s total exposure measure excluding on-balance sheet assets and securities financing transactions on the last day of each month in the quarter; and
2. (b) for the purposes of paragraphs 2(b) and 3, an LREQ firm must calculate its average leverage ratio for a quarter as its capital measure divided by its exposure measure where the:
1. (i) capital measure is the arithmetic mean of the firm’s tier 1 capital (leverage) on the last day of each month in the quarter; and
2. (ii) exposure measure is the sum derived in accordance with (a).

5.

1.

Institutions that are subject to Part Six shall disclose information on their liquidity coverage ratio, net stable funding ratio and liquidity risk management in accordance with this Article.

2.

Institutions shall disclose the following information in relation to their liquidity coverage ratio as calculated in accordance with the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook:

1. (a) the average or averages, as applicable, of their liquidity coverage ratio based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period;
2. (b) the average or averages, as applicable, of their total liquid assets, after applying the relevant haircuts, included in the liquidity buffer pursuant to the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook, based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period, and a description of the composition of that liquidity buffer;
3. (c) the averages of their liquidity outflows, inflows and net liquidity outflows as calculated in accordance with the Chapter 2 of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook, based on end-of-the-month observations over the preceding 12 months for each quarter of the relevant disclosure period and the description of their composition.

3.

Institutions shall disclose the following information in relation to their net stable funding ratio as calculated in accordance with Title IV of Part Six:

1. (a) averages of their net stable funding ratio calculated in accordance with Chapter 2 of Title IV of Part Six for each quarter of the relevant disclosure period, based on end-of-the-quarter observations over the preceding four quarters;
2. (b) an overview of the amount of available stable funding calculated in accordance with Chapter 3 of Title IV of Part Six for each quarter of the relevant disclosure period, comprising averages based on end-of-the-quarter observations over the preceding four quarters;
3. (c) an overview of the amount of required stable funding calculated in accordance with Chapter 4 of Title IV of Part Six for each quarter of the relevant disclosure period, comprising averages based on end-of-the-quarter observations over the preceding four quarters.

4.

Institutions shall disclose the arrangements, systems, processes and strategies put in place to identify, measure, manage and monitor their liquidity risk in accordance with the Internal Liquidity Adequacy Assessment Part of the PRA Rulebook.

6.1

Annex I Template UK OV1 can be found here Opens in a new window.

6.2

Annex I Template UK KM1 can be found here Opens in a new window.

6.3

Annex I Template UK INS1 can be found here Opens in a new window.

6.4

Annex I Template UK INS2 can be found here Opens in a new window.

6.5

Annex I Table UK OVC can be found here Opens in a new window.

6.6

Annex II can be found here Opens in a new window.

6.7

Annex III Table UK OVA can be found here Opens in a new window.

6.8

Annex III Table UK OVB can be found here Opens in a new window.

6.9

Annex IV can be found here Opens in a new window.

6.10

Annex V Template UK LI1 can be found here Opens in a new window.

6.11

Annex V Template UK LI2 can be found here Opens in a new window.

6.12

Annex V Template UK LI3 can be found here Opens in a new window.

6.13

Annex V Table UK LIA can be found here Opens in a new window.

6.14

Annex V Table UK LIB can be found here Opens in a new window.

6.15

Annex V Template UK PV1 can be found here Opens in a new window.

6.16

Annex VI can be found here Opens in a new window.

6.17

Annex VII Template UK CC1 can be found here Opens in a new window.

6.18

Annex VII Template UK CC2 can be found here Opens in a new window.

6.19

Annex VII Template UK CCA can be found here Opens in a new window.

6.20

Annex VIII can be found here Opens in a new window.

6.21

Annex IX Template UK CCyB1 can be found here Opens in a new window.

6.22

Annex IX Template UK CCyB2 can be found here Opens in a new window.

6.23

Annex X can be found here Opens in a new window.

6.24

Annex XI Templates UK LR1, UK LR2, UK LR3 and UK LRA can be found here Opens in a new window.

6.25

Annex XII can be found here Opens in a new window.

6.26

Annex XIII Table UK LIQA can be found here Opens in a new window.

6.27

Annex XIII Template UK LIQ1 can be found here Opens in a new window.

6.28

Annex XIII Table UK LIQB can be found here Opens in a new window.

6.29

Annex XIII Template UK LIQ2 can be found here Opens in a new window.

6.30

Annex XIV can be found here Opens in a new window.

6.30A

Annex XIV Table UK CRA can be found here Opens in a new window.

6.31

Annex XV Table UK CRB can be found here Opens in a new window.

6.32

Annex XV Template UK CR1 can be found here Opens in a new window.

6.33

Annex XV Template UK CR1-A can be found here Opens in a new window.

6.34

Annex XV Template UK CR2 can be found here Opens in a new window.

6.35

Annex XV Template UK CR2a can be found here Opens in a new window.

6.36

Annex XV Template UK CQ1 can be found here Opens in a new window.

6.37

Annex XV Template UK CQ2 can be found here Opens in a new window.

6.38

Annex XV Template UK CQ3 can be found here Opens in a new window.

6.39

Annex XV Template UK CQ4 can be found here Opens in a new window.

6.40

Annex XV Template UKCQ5 can be found here Opens in a new window.

6.41

Annex XV Template UK CQ6 can be found here Opens in a new window.

6.42

Annex XV Template UK CQ7 can be found here Opens in a new window.

6.43

Annex XV Template UK CQ8 can be found here Opens in a new window.

6.44

Annex XVI can be found here Opens in a new window.

6.45

Annex XVII Table UK CRC can be found here Opens in a new window.

6.46

Annex XVII Template UK CR3 can be found here Opens in a new window.

6.47

Annex XVIII can be found here Opens in a new window.

6.48

Annex XIX Table UK CRD can be found here Opens in a new window.

6.49

Annex XIX Template UK CR4 can be found here Opens in a new window.

6.50

Annex XIX Template UK CR5 can be found here Opens in a new window.

6.51

Annex XX can be found here Opens in a new window.

6.52

Annex XXI Table UK CRE can be found here Opens in a new window.

6.53

Annex XXI Template UK CR6 can be found here Opens in a new window.

6.54

Annex XXI Template UK CR6-A can be found here Opens in a new window.

6.55

Annex XXI Template UK CR7 can be found here Opens in a new window.

6.56

Annex XXI Template UK CR7-A can be found here Opens in a new window.

6.57

Annex XXI Template UK CR8 can be found here Opens in a new window.

6.58

Annex XXI Template UK CR9 can be found here Opens in a new window.

6.59

Annex XXI Template UK CR9.1 can be found here Opens in a new window.

6.60

Annex XXII can be found here Opens in a new window.

6.61

Annex XXIII Template UK CR10 can be found here Opens in a new window.

6.62

Annex XXIV can be found here Opens in a new window.

6.63

Annex XXV Table UK CCRA can be found here Opens in a new window.

6.64

Annex XXV Template UK CCR1 can be found here Opens in a new window.

6.65

Annex XXV Template UK CCR2 can be found here Opens in a new window.

6.66

Annex XXV Template UK CCR3 can be found here Opens in a new window.

6.67

Annex XXV Template UK CCR4 can be found here Opens in a new window.

6.68

Annex XXV Template UK CCR5 can be found here Opens in a new window.

6.69

Annex XXV Template UK CCR6 can be found here Opens in a new window.

6.70

Annex XXV Template UK CCR7 can be found here Opens in a new window.

6.71

Annex XXV Template UK CCR8 can be found here Opens in a new window.

6.72

Annex XXVI can be found here Opens in a new window.

6.73

Annex XXVII Table UK-SECA can be found here Opens in a new window.

6.74

Annex XXVII Template UK-SEC1 can be found here Opens in a new window.

6.75

Annex XXVII Template UK-SEC2 can be found here Opens in a new window.

6.76

Annex XXVII Template UK-SEC3 can be found here Opens in a new window.

6.77

Annex XXVII Template UK-SEC4 can be found here Opens in a new window.

6.78

Annex XXVII Template UK-SEC5 can be found here Opens in a new window.

6.79

Annex XXVIII can be found here Opens in a new window.

6.80

Annex XXIX Table UK MRA can be found here Opens in a new window.

6.81

Annex XXIX Template UK MR1 can be found here Opens in a new window.

6.82

Annex XXIX Table UK MRB can be found here Opens in a new window.

6.83

Annex XXIX Template UK MR2-A can be found here Opens in a new window.

6.84

Annex XXIX Template UK MR2-B can be found here Opens in a new window.

6.85

Annex XXIX Template UK MR3 can be found here Opens in a new window.

6.86

Annex XXIX Template UK MR4 can be found here Opens in a new window.

6.87

Annex XXX can be found here Opens in a new window.

6.88

Annex XXXI Table UK ORA can be found here Opens in a new window.

6.88A

Annex XXXI Template UK OR1 can be found here Opens in a new window.

6.89

Annex XXXII can be found here Opens in a new window.

6.90

Annex XXXIII Table UK REMA can be found here Opens in a new window.

6.91

Annex XXXIII Template UK REM1 can be found here Opens in a new window.

6.92

Annex XXXIII Template UK REM2 can be found here Opens in a new window.

6.93

Annex XXXIII Template UK REM3 can be found here Opens in a new window.

6.94

Annex XXXIII Template UK REM4 can be found here Opens in a new window.

6.95

Annex XXXIII Template UK REM5 can be found here Opens in a new window.

6.96

Annex XXXIV can be found here Opens in a new window.

6.97

Annex XXXV Template UK AE1 can be found here Opens in a new window.

6.98

Annex XXXV Template UK AE2 can be found here Opens in a new window.

6.99

Annex XXXV Template UK AE3 can be found here Opens in a new window.

6.100

Annex XXXV Table UK AE4 can be found here Opens in a new window.

6.101

Annex XXXVI can be found here Opens in a new window.

6.102

Annex XXXVII Template UK IRRBB1 can be found here Opens in a new window.

6.103

Annex XXXVII Table UK IRRBBA can be found here Opens in a new window.

6.104

Annex XXXVIII can be found here Opens in a new window.

3.2

[Deleted.]

3.3

[Deleted.]

3.4

[Deleted.]

3.5

[Deleted.]

3.6

[Deleted.]

3.7

[Deleted.]

3.8

[Deleted.]

3.9

[Deleted.]

3.10

[Deleted.]

3.11

[Deleted.]

3.12

[Deleted.]

3.13

[Deleted.]

3.14

[Deleted.]

3.15

[Deleted.]

3.16

[Deleted.]

3.17

[Deleted.]

3.18

[Deleted.]

3.19

[Deleted.]

3.20

[Deleted.]

3.21

[Deleted.]

3.22

[Deleted.]

3.23

[Deleted.]

3.24

[Deleted.]

3.25

[Deleted.]

3.26

[Deleted.]

3.27

[Deleted.]

3.28

[Deleted.]

3.29

[Deleted.]

3.30

[Deleted.]

3.31

[Deleted.]

3.32

[Deleted.]

3.33

[Deleted.]

3.34

[Deleted.]

3.35

[Deleted.]

3.36

[Deleted.]

3.37

[Deleted.]

3.38

[Deleted.]

3.39

[Deleted.]

3.40

[Deleted.]

3.41

[Deleted.]

3.42

[Deleted.]

3.43

[Deleted.]

3.44

[Deleted.]

3.45

[Deleted.]

3.46

[Deleted.]

3.47

[Deleted.]

3.48

[Deleted.]

3.49

[Deleted.]

3.50

[Deleted.]

3.51

[Deleted.]

3.52

[Deleted.]

3.53

[Deleted.]

3.54

[Deleted.]

3.55

[Deleted.]

3.56

[Deleted.]

3.57

[Deleted.]

3.58

[Deleted.]

3.59

[Deleted.]

3.60

[Deleted.]

3.61

[Deleted.]

3.62

[Deleted.]

3.63

[Deleted.]

3.64

[Deleted.]

3.65

[Deleted.]

3.66

[Deleted.]

3.67

[Deleted.]

3.68

[Deleted.]

3.69

[Deleted.]

3.70

[Deleted.]

3.71

[Deleted.]

3.72

[Deleted.]

3.73

[Deleted.]

3.74

[Deleted.]

3.75

[Deleted.]

3.76

[Deleted.]

3.77

[Deleted.]

3.78

[Deleted.]

3.79

[Deleted.]

3.80

[Deleted.]

3.81

[Deleted.]

3.82

[Deleted.]

3.83

[Deleted.]

3.84

[Deleted.]

3.85

[Deleted.]

3.86

[Deleted.]

3.87

[Deleted.]

3.88

[Deleted.]

3.89

[Deleted.]

3.90

[Deleted.]

3.91

[Deleted.]

3.92

[Deleted.]

3.93

[Deleted.]

3.94

[Deleted.]

3.95

[Deleted.]

3.96

[Deleted.]

3.97

[Deleted.]

3.98

[Deleted.]

3.99

[Deleted.]

3.100

[Deleted.]

3.101

[Deleted.]

3.102

[Deleted.]

3.103

[Deleted.]

3.104

[Deleted.]

3.105

[Deleted.]

7.1

In relation to any disclosure made after 31 December 2023 but relating to a period ending on or before 31 December 2023, a small CRR firm, an SDDT and an SDDT consolidation entity must apply this Part in accordance with Articles 433b and 433c as those Articles had effect on 31 December 2023.